EUVIMEDEUVIMED entdecken
Leitlinie

NCCN Guidelines® Insights: Colon Cancer, Version 3.2026

Al B Benson, Alan P Venook, Mohamed Adam, Manju Ambelil, Alexander Bray, George J Chang, Kristen K Ciombor, Stacey A Cohen, Madison Conces, Dustin Deming, Vaia Florou, Ignacio Garrido-Laguna und 33 weitere

Journal of the National Comprehensive Cancer Network · 2026-11 · 24 (11)

DOI: 10.6004/jnccn.2026.0051 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-11. Verfasst von Al B Benson und 44 weiteren Autor:innen. Beteiligte Einrichtung: 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Hauptthemen laut MEDLINE: Colonic Neoplasms. Die Arbeit nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Treatment of localized disease usually includes surgery, sometimes followed by adjuvant systemic therapy, while advanced or metastatic disease is often treated with multiple lines of systemic therapy, based on biomarker status. These NCCN Guidelines Insights detail recent updates to the NCCN Guidelines for Colon Cancer, including recommendations for pretreatment DPYD testing to decrease the risk of severe fluoropyrimidine toxicity; updates to adjuvant therapy of nonmetastatic colon cancer based on the results of recent clinical trials; and a reorganization of the systemic therapies for advanced or metastatic disease based on biomarker status, highlighting changes to the treatment recommendations for BRAF V600E mutation–positive disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsHumansBiomarkers, TumorProto-Oncogene Proteins B-rafMutation

Substanzen

Biomarkers, TumorProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • 2UCSF Helen Diller Family Comprehensive Cancer Center.
  • 3Fox Chase Cancer Center.
  • 4O'Neal Comprehensive Cancer Center at UAB.
  • 5The University of Texas MD Anderson Cancer Center.
  • 6Vanderbilt-Ingram Cancer Center.

Zitieren

APA

Benson, A. B., Venook, A. P., Adam, M., Ambelil, M., Bray, A., Chang, G. J., Ciombor, K. K., Cohen, S. A., Conces, M., Deming, D., Florou, V., Garrido-Laguna, I., Grem, J. L., Harmath, C., Haste, P., Hecht, J. R., Hicks, J. K., Hoffe, S., Hunt, S., …, & Gurski, L. (2026). NCCN Guidelines® Insights: Colon Cancer, Version 3.2026. Journal of the National Comprehensive Cancer Network, 24(11). https://doi.org/10.6004/jnccn.2026.0051

Vancouver

Benson AB, Venook AP, Adam M, Ambelil M, Bray A, Chang GJ, et al. NCCN Guidelines® Insights: Colon Cancer, Version 3.2026. Journal of the National Comprehensive Cancer Network. 2026;24(11). doi:10.6004/jnccn.2026.0051

BibTeX
@article{Benson2026,
  author = {Benson, Al B and Venook, Alan P and Adam, Mohamed and Ambelil, Manju and Bray, Alexander and Chang, George J and Ciombor, Kristen K and Cohen, Stacey A and Conces, Madison and Deming, Dustin and Florou, Vaia and Garrido-Laguna, Ignacio and Grem, Jean L and Harmath, Carla and Haste, Paul and Hecht, J Randolph and Hicks, J Kevin and Hoffe, Sarah and Hunt, Steven and Hussan, Hisham and Johung, Kimberly L and Joseph, Nora and Kirilcuk, Natalie and Malla, Midhun and Mannan, Rifat and Maratt, Jennifer K and Messersmith, Wells A and Meyer, Jeffrey and Meyerhardt, Jeffrey and Miller, Eric D and Mulcahy, Mary F and Nurkin, Steven and Patel, Hitendra and Pedersen, Katrina and Saltz, Leonard and Schneider, Charles and Shibata, David and Shogan, Benjamin and Singer, Laurie and Sofocleous, Constantinos T and Tavakkoli, Anna and Willett, Christopher G and Wu, Christina and Jones, Frankie and Gurski, Lisa},
  title = {NCCN Guidelines® Insights: Colon Cancer, Version 3.2026},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {11},
  doi = {10.6004/jnccn.2026.0051}
}
Kostenlos starten →